Empowered Funds’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.3M Buy
43,981
+25,886
+143% +$13.1M 0.13% 157
2025
Q4
$10.2M Buy
18,095
+2,508
+16% +$1.34M 0.17% 130
2025
Q3
$6.97M Buy
15,587
+3,794
+32% +$1.82M 0.07% 378
2025
Q2
$6.41M Buy
11,793
+2,465
+26% +$1.29M 0.07% 369
2025
Q1
$4.62M Sell
9,328
-13,678
-59% -$7.56M 0.07% 406
2024
Q4
$12M Buy
23,006
+14,829
+181% +$7.72M 0.18% 107
2024
Q3
$4.02M Buy
8,177
+345
+4% +$161K 0.06% 427
2024
Q2
$3.48M Buy
7,832
+739
+10% +$294K 0.06% 429
2024
Q1
$2.83M Buy
7,093
+354
+5% +$134K 0.05% 488
2023
Q4
$2.27M Buy
6,739
+601
+10% +$179K 0.06% 481
2023
Q3
$1.79M Buy
6,138
+507
+9% +$158K 0.05% 483
2023
Q2
$1.93M Buy
5,631
+889
+19% +$269K 0.07% 406
2023
Q1
$1.21M Buy
4,742
+3,654
+336% +$900K 0.07% 259
2022
Q4
$289K Buy
+1,088
New +$265K 0.02% 400
2018
Q2
Sell
-8,718
Closed -$1.17M 109
2018
Q1
$1.17M Buy
8,718
+1,503
+21% +$210K 0.43% 68
2017
Q4
$878K Buy
+7,215
New +$903K 0.44% 88

Other funds holding ISRG

Empowered Funds's ISRG Position: Q1 2026 in Review

Empowered Funds increased its Intuitive Surgical (ISRG) stake by 143% in Q1 2026, buying an estimated $13.1M and bringing the position to 43,981 shares worth $20.3M. The position accounts for 0.13% of the portfolio, ranked #157.

Empowered Funds first reported a position in ISRG in Q4 2017 and has held it in 16 quarters since. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Empowered Funds held 43,981 shares of Intuitive Surgical worth $20.3M as of Q1 2026.
  • Empowered Funds bought 25,886 Intuitive Surgical shares in Q1 2026, an estimated $13.1M.
  • Intuitive Surgical made up 0.13% of Empowered Funds's portfolio in Q1 2026, its #157 holding.
  • Empowered Funds first reported a position in Intuitive Surgical in Q4 2017 and has held it in 16 quarters since.
  • 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.